targeted sequencing
Illumina, GenoScreen Partner to Comarket Genomic Testing for Multidrug-Resistant TB
The firms will comarket Illumina next-generation sequencing reagents with GenoScreen's Deeplex Myc-TB NGS-based test for antibiotic resistance in TB.
The firm can now be reimbursed $355 for its microbe sequencing tests, which it said sets a competitive bar for other developers.
The multi-year project led by FIND is currently evaluating three end-to-end solutions through clinical studies.
Twist Bioscience, Centogene Partner on NGS-Based Rare Disease Genetic Testing
The partners will design multiple assay kits in an attempt to make genetic testing for rare diseases more accessible to patients.
Genetron Health, Siemens Healthineers Partner to Promote Lung Cancer Molecular Testing in China
The companies will work together to increase adoption of Genetron's sequencing platform and lung cancer diagnostic assay in Chinese hospitals.
Mar 11, 2021
Burning Rock Q4 Revenues Rise 50 Percent
Dec 9, 2020
Nov 24, 2020
Tempus Gets CE Mark for xT Tumor Sequencing Assay
May 12, 2020
Adaptive Biotechnologies Q1 Revenues Grow 65 Percent
Mar 10, 2020